| Literature DB >> 30319245 |
Yong Hui Nies1, Adliah Mhd Ali1, Norlia Abdullah2, Farida Islahudin1, Noraida Mohamed Shah1.
Abstract
PURPOSE: The objective of this study was to explore the experiences and side-effects of breast cancer patients on chemotherapy in Malaysia. PARTICIPANTS AND METHODS: Purposive sampling of 36 breast cancer patients who have completed chemotherapy and agreed to participate in semi-structured in-depth interviews. A constant comparative method and thematic analysis were used to analyze the interviews.Entities:
Keywords: Malaysia; breast cancer; chemotherapy; clinical pharmacy service; semi-structured interview
Year: 2018 PMID: 30319245 PMCID: PMC6167974 DOI: 10.2147/PPA.S168638
Source DB: PubMed Journal: Patient Prefer Adherence ISSN: 1177-889X Impact factor: 2.711
Description of the breast cancer patients from qualitative interview
| Patient | Age | Gender | Ethnicity | Stage of cancer | Treatment(s) |
|---|---|---|---|---|---|
| IV001 | 47 | Female | Malay | 4 | Surgery, adjuvant chemotherapy, hormonal therapy |
| IV002 | 60 | Female | Malay | 3 | Surgery, adjuvant chemotherapy, radiotherapy, hormonal therapy |
| IV003 | 50 | Female | Malay | 4 | Neoadjuvant chemotherapy, surgery, radiotherapy |
| IV004 | 62 | Female | Chinese | 1 | Surgery, adjuvant chemotherapy, radiotherapy |
| IV005 | 56 | Female | Malay | 3 | Surgery, adjuvant chemotherapy, hormonal therapy |
| IV006 | 52 | Female | Malay | 2 | Surgery, adjuvant chemotherapy, radiotherapy, hormonal therapy |
| IV007 | 51 | Female | Malay | 3 | Surgery, adjuvant chemotherapy, radiotherapy, targeted therapy |
| IV008 | 47 | Female | Malay | 2 | Surgery, adjuvant chemotherapy, radiotherapy |
| IV009 | 59 | Female | Malay | 2 | Surgery, adjuvant chemotherapy, targeted therapy |
| IV010 | 46 | Female | Malay | 4 | Surgery, palliative chemotherapy |
| IV011 | 66 | Female | Chinese | 2 | Surgery, adjuvant chemotherapy |
| IV012 | 68 | Female | Malay | 2 | Surgery, adjuvant chemotherapy, radiotherapy, hormonal therapy |
| IV013 | 61 | Female | Malay | 2 | Neoadjuvant chemotherapy, surgery, radiotherapy |
| IV014 | 52 | Female | Chinese | 3 | Surgery, adjuvant chemotherapy, hormonal therapy, radiotherapy |
| IV015 | 34 | Female | Malay | 3 | Neoadjuvant chemotherapy, surgery, radiotherapy, hormonal therapy |
| IV016 | 37 | Female | Malay | 4 | Neoadjuvant chemotherapy, surgery, radiotherapy, hormonal therapy |
| IV017 | 49 | Female | Malay | 2 | Surgery, adjuvant chemotherapy, radiotherapy |
| IV018 | 51 | Male | Chinese | 3 | Neoadjuvant chemotherapy, surgery, radiotherapy |
| IV019 | 59 | Female | Indian | 3 | Surgery, adjuvant chemotherapy, radiotherapy, hormonal therapy |
| IV020 | 65 | Female | Malay | 2 | Surgery, adjuvant chemotherapy |
| IV021 | 59 | Female | Malay | 2 | Surgery, adjuvant chemotherapy |
| IV022 | 37 | Female | Chinese | 1 | Surgery, adjuvant chemotherapy, radiotherapy, hormonal therapy |
| IV023 | 53 | Female | Chinese | 2 | Surgery, adjuvant chemotherapy, radiotherapy, hormonal therapy |
| IV024 | 55 | Female | Malay | 2 | Surgery, adjuvant chemotherapy, radiotherapy |
| IV025 | 55 | Female | Malay | 2 | Surgery, adjuvant chemotherapy, radiotherapy, hormonal therapy |
| IV026 | 68 | Female | Chinese | 3 | Surgery, adjuvant chemotherapy, radiotherapy |
| IV027 | 51 | Female | Malay | 3 | Surgery, adjuvant chemotherapy, radiotherapy |
| IV028 | 38 | Female | Malay | 3 | Surgery, adjuvant chemotherapy, radiotherapy |
| IV029 | 63 | Female | Chinese | 2 | Surgery, adjuvant chemotherapy, radiotherapy, hormonal therapy |
| IV030 | 61 | Female | Chinese | 2 | Surgery, adjuvant chemotherapy, radiotherapy |
| IV031 | 58 | Female | Indian | 1 | Surgery, adjuvant chemotherapy, radiotherapy |
| IV032 | 57 | Female | Malay | 3 | Neoadjuvant chemotherapy, surgery, radiotherapy |
| IV033 | 71 | Female | Indian | 3 | Surgery, adjuvant chemotherapy, radiotherapy |
| IV034 | 39 | Female | Malay | 2 | Surgery, adjuvant chemotherapy, radiotherapy |
| IV035 | 42 | Female | Malay | 2 | Surgery, adjuvant chemotherapy, radiotherapy, hormonal therapy |
| IV036 | 34 | Female | Malay | 3 | Neoadjuvant chemotherapy, surgery, radiotherapy |
Systematic symptoms/signs during chemotherapy (not exclusive)
| Signs/symptoms | Number of cases (%) |
|---|---|
| Breathing difficulty | 4 (11.1) |
| Cold | 2 (5.6) |
| Constipation | 3 (8.3) |
| Coughing | 5 (13.9) |
| Cracked lips/dry mouth | 22 (61.1) |
| Darkened nails | 4 (11.1) |
| Diarrhea | 2 (5.6) |
| Dizziness | 7 (19.4) |
| Dry eye | 1 (2.8) |
| Dry skin | 2 (5.6) |
| Fever | 13 (33.3) |
| Flu | 1 (2.8) |
| Hair loss | 24 (66.7) |
| Headache | 3 (8.3) |
| Insomnia | 13 (36.1) |
| Loss of appetite | 19 (52.8) |
| Nausea | 7 (19.4) |
| Sore throat | 1 (2.8) |
| Tasteless | 7 (19.4) |
| Tired/fatigue | 16 (44.4) |
| Toothache | 2 (5.6) |
| Ulcer | 5 (13.9) |
| Vomiting | 21 (58.3) |
| Warm | 11 (30.6) |
The number of patients who expressed a given theme
| Theme | Number of patients (N=36) | Percentage of patients (%) |
|---|---|---|
| Know nothing of chemotherapy | 6 | 16.67 |
| Fear of chemotherapy | 10 | 27.78 |
| Patients’ beliefs in alternative treatment | 15 | 41.67 |
| Symptom management | 20 | 55.56 |
| Staying healthy after chemotherapy | 4 | 11.11 |
| Concerns of patients after chemotherapy | 11 | 30.56 |
The number of patients who expressed a given subtheme
| Subtheme | Number of patients (N=36) | Percentage of patients (%) |
|---|---|---|
| Lack of knowledge about chemotherapy | 6 | 16.67 |
| The consequences after receiving chemotherapy | 9 | 25.00 |
| Fear of hospitalization | 1 | 2.78 |
| Concurrent use of complementary and alternative medicine with chemotherapy | 11 | 30.56 |
| Patients’ perception towards the impact of complementary and alternative medicines on cancer | 4 | 11.11 |
| Quarantined themselves and tolerated the side-effects passively | 5 | 13.89 |
| Solutions to encounter appetite problem | 5 | 13.89 |
| Lifestyle adjustments | 3 | 8.33 |
| Encountering the impact of chemotherapy positively | 7 | 19.44 |
| Avoid the crowd to prevent infection | 4 | 11.11 |
| Worrying about the possibility of recurrence in future | 11 | 30.56 |